Inosine Pranobex (IP) - possibilities of its use in the treatment of COVID19

<p>The finding that enzymes of purine metabolism interfere to the regulation of immune events is known from the findings of Giblett, et al. [1], that Adenosine Deaminase (ADA) deficiency leads to Severe Combined Immunbodeficiency (SCID), The same author described in 1975 case of  T-immune defi...

Full description

Saved in:
Bibliographic Details
Main Author: Svetozár Dluholucký (Author)
Format: Book
Published: Archives of Community Medicine and Public Health - Peertechz Publications, 2020-09-01.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-5479_000106
042 |a dc 
100 1 0 |a Svetozár Dluholucký  |e author 
245 0 0 |a Inosine Pranobex (IP) - possibilities of its use in the treatment of COVID19 
260 |b Archives of Community Medicine and Public Health - Peertechz Publications,   |c 2020-09-01. 
520 |a <p>The finding that enzymes of purine metabolism interfere to the regulation of immune events is known from the findings of Giblett, et al. [1], that Adenosine Deaminase (ADA) deficiency leads to Severe Combined Immunbodeficiency (SCID), The same author described in 1975 case of  T-immune deficiency caused by a deficiency of another purine metabolism enzyme - Purine Nucleoside Phosphorylase (PNP). Subsequently, otherl authors have described cases of hypo to agammaglobulinemia with 5´-nucleotidase (5-NT) deficiency in adults [2] and children [3].</p> 
540 |a Copyright © Svetozár Dluholucký et al. 
546 |a en 
655 7 |a Short Communication  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-5479.000106  |z Connect to this object online.